Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024)

Historic Amortization of Deferred Charges for Neuroone Medical Technologies (NMTC) over the last 3 years, with Q4 2024 value amounting to $192647.0.

  • Neuroone Medical Technologies' Amortization of Deferred Charges changed N/A to $192647.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $192647.0, marking a year-over-year change of. This contributed to the annual value of $192647.0 for FY2025, which is 9012.03% up from last year.
  • According to the latest figures from Q4 2024, Neuroone Medical Technologies' Amortization of Deferred Charges is $192647.0.
  • In the past 5 years, Neuroone Medical Technologies' Amortization of Deferred Charges registered a high of $192647.0 during Q4 2024, and its lowest value of $192647.0 during Q4 2024.